Publications by authors named "Zuzanna Mielczarek"
Postep Psychiatr Neurol
September 2023
Article Synopsis
- Lurasidon is a new second-generation antipsychotic drug known for its safety and low side effect profile, mainly impacting dopamine and serotonin receptors.
- A case study is presented involving a 39-year-old man with paranoid schizophrenia who developed neutropenia while taking lurasidone, but his condition improved after discontinuing the drug and receiving supplementation.
- The findings highlight the importance of regularly monitoring blood cell levels in patients on second-generation antipsychotics to detect risks like neutropenia and agranulocytosis.
